Menu
Your Cart

Gerpevir time. for solution for infection. 250 mg fl. No. 10

Gerpevir time. for solution for infection. 250 mg fl. No. 10
Gerpevir time. for solution for infection. 250 mg fl. No. 10
Gerpevir time. for solution for infection. 250 mg fl. No. 10
Gerpevir time. for solution for infection. 250 mg fl. No. 10
Gerpevir time. for solution for infection. 250 mg fl. No. 10
$67.59
Tax $67.59
  • Stock: In Stock
  • Model: 179058

0% Customers recommend this product

  • 5 Awesome
    0%
  • 4 Great
    0%
  • 3 Average
    0%
  • 2 Bad
    0%
  • 1 Poor
    0%

Reviews Over Gerpevir time. for solution for infection. 250 mg fl. No. 10

  • (0)

Total Reviews (0)
click here write review to add review for this product.



Description

Powder for solution for injections Gerpevir is shown for treatment of the infections caused by a herpes simplex virus at patients with an immunodeficiency and heavy genital herpes at patients without immunodeficiency.

Structure

Active ingredient: aciclovir;

1 bottle contains

acyclovir of sodium salt sterile in terms of acyclovir – 250 mg.

Contraindication

Hypersensitivity to acyclovir, a valatsiklovir.

Route of administration

is Applied by slow intravenous infusion within not less than 1 hour.

Course of treatment Gerpevir for intravenous administration usually lasts 5 days, but duration can be changed depending on a condition of the patient and the corresponding reaction to therapy. Treatment of herpes simplex encephalitis lasts usually 10 days. Treatment of infections at the newborns called by a herpes simplex virus lasts usually 14 days at damage of skin and mucous membranes and 21 days – at dissimination and damage of the central nervous system.

Duration of preventive application of Gerpevir for intravenous administration is defined by duration of the period of risk of infection.

Feature of application

Pregnant

needs to Apply acyclovir to infusions only in cases when the potential advantage for mother of use of medicine exceeds possible risk for a fruit.

Children

to Apply

since the birth.

Drivers

Gerpevir for intravenous administration is mainly applied by

to treatment of the patients who are on hospital treatment therefore usually information on influence on ability to drive the car and other mechanisms is not necessary. Researches on studying influence of medicine on ability to drive the car and other mechanisms were not conducted.

Overdose

At overdose of acyclovir by intravenous administration increases the level of serumal creatinine, urea nitrogen of blood and, respectively, the renal failure develops. The confusion of consciousness, a hallucination, excitement, spasms and a coma can be neurologic manifestations of overdose.

Acyclovir is very well removed by

from blood by means of a hemodialysis therefore this method can be applied successfully at medicine overdose treatment.

Side effects

  • Cardiovascular system. Often: phlebitis.
  • Gastroenterological system. Often: nausea, vomiting.
  • Gepatobiliarnaya system. Often: reversible increase in level of liver enzymes.
  • Skin and hypodermic fabrics. Often: an itch, urticaria, rash (including photosensitivity).
  • Kidney and urinary system. Often: increase in level of urea and creatinine in blood.

Interaction

was not revealed by

Clinically important interaction of acyclovir with other medicines.

Acyclovir is mainly emitted to

in not changed look with kidneys by canalicular secretion therefore any medicaments having the similar mechanism of discharge can increase concentration of acyclovir in plasma.

Probenetsid and Cimetidinum increase elimination half-life of acyclovir and increase the area under a curve concentration/time, but, considering the wide therapeutic index of acyclovir, it is not necessary to adjust a dose.

Storage conditions

are not higher than

In original packing at a temperature 25ºС.

to Store

out of children's reach.

Expiration date - 5 years.

Specifications

Characteristics
Active ingredients Acyclovir
Amount of active ingredient 250 mg
Applicant Arterium
Code of automatic telephone exchange J05AB01 Acyclovir
Interaction with food It doesn't matter
Light sensitivity Not sensitive
Market status The branded generic
Origin Chemical
Prescription status According to the prescription
Primary packing bottle
Producer KIYEVMEDPREPARAT OF JOINT STOCK COMPANY
Quantity in packing 10 pieces.
Release form powder for injections
Route of administration Infusional
Sign Domestic
Storage temperature from 5 °C to 25 °C
Trade name Gerpevir